Latest multiple sclerosis Stories
Net Sales $279 Million; Increase of 42% over Prior Year Non-GAAP Results ANAHEIM, Calif., July 24, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.
Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- Largest Global Scientific, Research and Medical Gathering of Professionals Advancing Research and Treatment in Multiple Sclerosis - BOSTON, July 17, 2014 /PRNewswire/ -- The upcoming 2014
Every Month Hands-On Physical Therapy Raises Money for an Important Cause: This Month Was the Fight Against Multiple Sclerosis Astoria, New York (PRWEB) July
DailyGossip.org publishes a useful review to the Natural Multiple Sclerosis Cure program to help patients find a way to feel better and eliminate symptoms Denver,
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.
The Conrad N.
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.
More Images (1 images) »